Puma Biotechnology Stock Investor Sentiment

PBYI Stock  USD 5.77  0.18  3.03%   
Under 58% of Puma Biotechnology's investor base is looking to short. The analysis of the overall investor sentiment regarding Puma Biotechnology suggests that many traders are alarmed. Puma Biotechnology's investing sentiment shows overall attitude of investors towards Puma Biotechnology.

Comfort Level 42

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Puma Biotechnology's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Puma Biotechnology.

Puma Historical Sentiment

Although Puma Biotechnology's investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Puma, such as negative comments on social media and news outlets, may cause fear in the market and push Puma Biotechnology's investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Puma.

Puma Biotechnology Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Puma Biotechnology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Puma Biotechnology Historical Investor Sentiment

Investor biases related to Puma Biotechnology's public news can be used to forecast risks associated with an investment in Puma. The trend in average sentiment can be used to explain how an investor holding Puma can time the market purely based on public headlines and social activities around Puma Biotechnology. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Puma Biotechnology's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Puma Biotechnology and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Puma Biotechnology news discussions. The higher the estimate score, the more favorable the investor's outlook on Puma Biotechnology.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Puma Biotechnology's Stock prices. Below is the latest headlines and news related to Puma Biotechnology Stock. Current markets are strongly bullish. About 77% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Puma Biotechnology that are available to investors today. This information is accessible both publicly - through Puma Biotechnology's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Puma-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Puma Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Puma Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Puma Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Puma Biotechnology alpha.

Puma Largest EPS Surprises

Earnings surprises can significantly impact Puma Biotechnology's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-08-01
2024-06-30-0.13-0.090.0430 
2024-02-29
2023-12-310.30.26-0.0413 
2023-11-02
2023-09-300.080.120.0450 
2023-08-03
2023-06-300.010.050.04400 
2022-11-03
2022-09-30-0.05-0.010.0480 
2025-10-30
2025-09-300.1550.210.05535 
View All Earnings Estimates
few days ago at finance.yahoo.com         
Up 91 percent in the Past Year, Is This Biotech Stock Red Hot or a Red Flag?
Yahoo News
few days ago at news.google.com         
Puma Biotechnology Shares Cross Above 200 Day Moving Average - Heres What Happened - MarketBeat
Google News at Macroaxis
over a week ago at finance.yahoo.com         
Puma Biotechnology Added to the NASDAQ Biotechnology Index
Yahoo News
over a week ago at finance.yahoo.com         
If EPS Growth Is Important To You, Puma Biotechnology Presents An Opportunity
Yahoo News
over two weeks ago at news.google.com         
How Puma Biotechnology Inc. stock reacts to oil prices - Portfolio Value Report Low Risk High Reward...
Google News at Macroaxis
over two weeks ago at news.google.com         
How Puma Biotechnology Inc. stock reacts to oil prices - Weekly Risk Report AI Driven Stock Reports ...
Google News at Macroaxis
over two weeks ago at finance.yahoo.com         
CRMD vs. PBYI Which Small-Cap Biotech Stock Is the Better Buy?
Yahoo News
over two weeks ago at zacks.com         
CRMD vs. PBYI Which Small-Cap Biotech Stock Is the Better Buy?
zacks News
over two weeks ago at news.google.com         
Why analysts upgrade Puma Biotechnology Inc stock - 2025 Winners Losers Consistent Income Trade Idea...
Google News at Macroaxis
over two weeks ago at news.google.com         
Acorn Capital Advisors LLC Has 14.17 Million Stake in Puma Biotechnology, Inc. PBYI - MarketBeat
Google News at Macroaxis
over three weeks ago at simplywall.st         
With EPS Growth And More, Puma Biotechnology Makes An Interesting Case
Simply Wall St News at Macroaxis
over three weeks ago at news.google.com         
Is Puma Biotechnology Stock Built to Withstand a Pullback - Trefis
Google News at Macroaxis
over three weeks ago at news.google.com         
Can Puma Biotechnology Stock Hold Up When Markets Turn - Trefis
Google News at Macroaxis
over a month ago at news.google.com         
What insider trading reveals about Puma Biotechnology Inc. stock - 2025 Top Gainers Daily Oversold B...
Google News at Macroaxis
over a month ago at finance.yahoo.com         
December 2025s Promising Penny Stocks To Consider
Yahoo News
There is far too much social signal, news, headlines, and media speculation about Puma Biotechnology that are available to investors today. This information is accessible both publicly - through Puma Biotechnology's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Puma-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Puma Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Puma Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Puma Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Puma Biotechnology alpha.

Puma Biotechnology Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
How strong is Puma Biotechnology Inc. stock revenue growth - Market Performance Report AI Forecast for Swing Trade Picks - newser.com
11/03/2025
2
Disposition of 20000 shares by Miller Michael Patrick of Puma Biotechnology at 4.8614 subject to Rule 16b-3
11/11/2025
3
Top Penny Stocks To Watch In November 2025
11/13/2025
4
1stdibs.Com And 2 Other Penny Stocks To Watch Closely
11/18/2025
5
Spotlight On 3 Promising Penny Stocks Under 800M Market Cap
11/24/2025
6
GoodRx Holdings And 2 Other Promising Penny Stocks
11/26/2025
7
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635
12/02/2025
8
CRMD vs. PBYI Which Small-Cap Biotech Stock Is the Better Buy
12/17/2025
9
Up 91 percent in the Past Year, Is This Biotech Stock Red Hot or a Red Flag
12/31/2025

Complementary Tools for Puma Stock analysis

When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Transaction History
View history of all your transactions and understand their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.